nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylpropanolamine—SLC6A2—locus ceruleus—narcolepsy	0.0943	0.197	CbGeAlD
Phenylpropanolamine—MAOA—locus ceruleus—narcolepsy	0.0869	0.181	CbGeAlD
Phenylpropanolamine—SLC6A2—autonomic nervous system—narcolepsy	0.0501	0.104	CbGeAlD
Phenylpropanolamine—DRD1—brainstem—narcolepsy	0.0187	0.0389	CbGeAlD
Phenylpropanolamine—DRD1—forebrain—narcolepsy	0.018	0.0375	CbGeAlD
Phenylpropanolamine—SLC6A3—brainstem—narcolepsy	0.015	0.0313	CbGeAlD
Phenylpropanolamine—SLC6A3—forebrain—narcolepsy	0.0145	0.0302	CbGeAlD
Phenylpropanolamine—ADRB1—forebrain—narcolepsy	0.0137	0.0286	CbGeAlD
Phenylpropanolamine—SLC6A2—brainstem—narcolepsy	0.0121	0.0252	CbGeAlD
Phenylpropanolamine—DRD1—midbrain—narcolepsy	0.0119	0.0248	CbGeAlD
Phenylpropanolamine—SLC6A2—forebrain—narcolepsy	0.0117	0.0243	CbGeAlD
Phenylpropanolamine—ADRA1A—brainstem—narcolepsy	0.0112	0.0234	CbGeAlD
Phenylpropanolamine—MAOA—brainstem—narcolepsy	0.0111	0.0232	CbGeAlD
Phenylpropanolamine—ADRA1A—forebrain—narcolepsy	0.0109	0.0226	CbGeAlD
Phenylpropanolamine—MAOA—forebrain—narcolepsy	0.0108	0.0224	CbGeAlD
Phenylpropanolamine—SLC6A3—midbrain—narcolepsy	0.00956	0.0199	CbGeAlD
Phenylpropanolamine—SLC6A2—medulla oblongata—narcolepsy	0.00844	0.0176	CbGeAlD
Phenylpropanolamine—ADRA2A—forebrain—narcolepsy	0.00825	0.0172	CbGeAlD
Phenylpropanolamine—MAOA—medulla oblongata—narcolepsy	0.00777	0.0162	CbGeAlD
Phenylpropanolamine—DRD1—brain—narcolepsy	0.00747	0.0156	CbGeAlD
Phenylpropanolamine—MAOA—midbrain—narcolepsy	0.0071	0.0148	CbGeAlD
Phenylpropanolamine—SLC6A3—brain—narcolepsy	0.00601	0.0125	CbGeAlD
Phenylpropanolamine—ADRA2A—medulla oblongata—narcolepsy	0.00596	0.0124	CbGeAlD
Phenylpropanolamine—ADRB1—brain—narcolepsy	0.0057	0.0119	CbGeAlD
Phenylpropanolamine—ADRA2A—midbrain—narcolepsy	0.00545	0.0114	CbGeAlD
Phenylpropanolamine—SLC6A2—brain—narcolepsy	0.00485	0.0101	CbGeAlD
Phenylpropanolamine—ADRA1A—brain—narcolepsy	0.0045	0.00939	CbGeAlD
Phenylpropanolamine—MAOA—brain—narcolepsy	0.00446	0.00931	CbGeAlD
Phenylpropanolamine—ADRA2A—brain—narcolepsy	0.00343	0.00714	CbGeAlD
Phenylpropanolamine—Pseudoephedrine—TNF—narcolepsy	0.00292	1	CrCbGaD
Phenylpropanolamine—DRD1—GPCR ligand binding—HCRT—narcolepsy	0.00197	0.0038	CbGpPWpGaD
Phenylpropanolamine—DRD1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00196	0.00379	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—G alpha (i) signalling events—PENK—narcolepsy	0.00196	0.00378	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.00192	0.00372	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00188	0.00363	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.0018	0.00348	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR ligand binding—HCRT—narcolepsy	0.00177	0.00342	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00176	0.00341	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00176	0.0034	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR ligand binding—PENK—narcolepsy	0.00175	0.00339	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00175	0.00338	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR ligand binding—HCRTR2—narcolepsy	0.00174	0.00337	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR ligand binding—HCRTR1—narcolepsy	0.00174	0.00337	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR ligand binding—HCRT—narcolepsy	0.00173	0.00335	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00172	0.00333	CbGpPWpGaD
Phenylpropanolamine—DRD1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00172	0.00332	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR ligand binding—P2RY11—narcolepsy	0.00168	0.00325	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00168	0.00324	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR ligand binding—HCRTR2—narcolepsy	0.00162	0.00313	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR ligand binding—HCRTR1—narcolepsy	0.00162	0.00313	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR ligand binding—PENK—narcolepsy	0.00158	0.00305	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR ligand binding—P2RY11—narcolepsy	0.00156	0.00302	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—G alpha (q) signalling events—NPS—narcolepsy	0.00156	0.00302	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—G alpha (q) signalling events—TAC1—narcolepsy	0.00156	0.00302	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00156	0.00301	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00154	0.00298	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR ligand binding—PENK—narcolepsy	0.00154	0.00298	CbGpPWpGaD
Phenylpropanolamine—MAOA—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.00151	0.00292	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00151	0.00292	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR ligand binding—TRH—narcolepsy	0.00149	0.00288	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—G alpha (i) signalling events—HRH3—narcolepsy	0.00146	0.00282	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00146	0.00282	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR ligand binding—HCRT—narcolepsy	0.00143	0.00277	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00142	0.00275	CbGpPWpGaD
Phenylpropanolamine—DRD1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00142	0.00275	CbGpPWpGaD
Phenylpropanolamine—DRD1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00142	0.00275	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.0014	0.0027	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.0014	0.0027	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00135	0.00262	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR downstream signaling—HCRTR2—narcolepsy	0.00135	0.00262	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR downstream signaling—HCRTR1—narcolepsy	0.00135	0.00262	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR ligand binding—TRH—narcolepsy	0.00134	0.00259	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR ligand binding—HCRT—narcolepsy	0.00133	0.00257	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00132	0.00256	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR ligand binding—TRH—narcolepsy	0.00131	0.00254	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR downstream signaling—P2RY11—narcolepsy	0.00131	0.00253	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR ligand binding—HRH3—narcolepsy	0.00131	0.00253	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00128	0.00247	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00128	0.00247	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR ligand binding—PENK—narcolepsy	0.00128	0.00247	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00125	0.00242	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00125	0.00242	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00125	0.00241	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—HCRTR2—narcolepsy	0.00123	0.00238	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—HCRTR1—narcolepsy	0.00123	0.00238	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—HCRTR2—narcolepsy	0.00122	0.00235	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—HCRTR1—narcolepsy	0.00122	0.00235	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—HCRTR1—narcolepsy	0.00119	0.0023	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—HCRTR2—narcolepsy	0.00119	0.0023	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—P2RY11—narcolepsy	0.00119	0.0023	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR ligand binding—PENK—narcolepsy	0.00119	0.00229	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—P2RY11—narcolepsy	0.00118	0.00227	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR ligand binding—HRH3—narcolepsy	0.00118	0.00227	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00116	0.00224	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—P2RY11—narcolepsy	0.00115	0.00222	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR ligand binding—HRH3—narcolepsy	0.00115	0.00222	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR downstream signaling—HCRT—narcolepsy	0.00111	0.00215	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—HCRTR1—narcolepsy	0.00111	0.00214	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—HCRTR2—narcolepsy	0.00111	0.00214	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR ligand binding—TRH—narcolepsy	0.00108	0.0021	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR ligand binding—NPS—narcolepsy	0.00108	0.00209	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR ligand binding—TAC1—narcolepsy	0.00108	0.00209	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—HCRTR1—narcolepsy	0.00108	0.00209	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—HCRTR2—narcolepsy	0.00108	0.00209	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—P2RY11—narcolepsy	0.00107	0.00206	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—P2RY11—narcolepsy	0.00104	0.00202	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00104	0.002	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00104	0.002	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—HCRT—narcolepsy	0.00101	0.00195	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR ligand binding—TRH—narcolepsy	0.00101	0.00195	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—HCRT—narcolepsy	0.001	0.00193	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000999	0.00193	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—CHKB—narcolepsy	0.000998	0.00193	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR downstream signaling—PENK—narcolepsy	0.000991	0.00192	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—HCRTR2—narcolepsy	0.000985	0.0019	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—HCRTR1—narcolepsy	0.000985	0.0019	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—HCRT—narcolepsy	0.000978	0.00189	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR ligand binding—TAC1—narcolepsy	0.000974	0.00188	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR ligand binding—NPS—narcolepsy	0.000974	0.00188	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.000962	0.00186	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.000962	0.00186	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR ligand binding—NPS—narcolepsy	0.000953	0.00184	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR ligand binding—TAC1—narcolepsy	0.000953	0.00184	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—P2RY11—narcolepsy	0.000951	0.00184	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR ligand binding—HRH3—narcolepsy	0.000951	0.00184	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—G alpha (q) signalling events—HTR2A—narcolepsy	0.00094	0.00182	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—HCRTR2—narcolepsy	0.000915	0.00177	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—HCRTR1—narcolepsy	0.000915	0.00177	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—HCRT—narcolepsy	0.000908	0.00176	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—PENK—narcolepsy	0.0009	0.00174	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000898	0.00174	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—HCRTR2—narcolepsy	0.000895	0.00173	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—HCRTR1—narcolepsy	0.000895	0.00173	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—PENK—narcolepsy	0.000891	0.00172	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—HCRT—narcolepsy	0.000888	0.00172	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—P2RY11—narcolepsy	0.000884	0.00171	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR ligand binding—HRH3—narcolepsy	0.000884	0.00171	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000879	0.0017	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—PENK—narcolepsy	0.000872	0.00169	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—P2RY11—narcolepsy	0.000864	0.00167	CbGpPWpGaD
Phenylpropanolamine—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000856	0.00165	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR downstream signaling—TRH—narcolepsy	0.000843	0.00163	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.000841	0.00163	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—HCRTR2—narcolepsy	0.000831	0.00161	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—HCRTR1—narcolepsy	0.000831	0.00161	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.000827	0.0016	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—PENK—narcolepsy	0.000809	0.00156	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—HCRT—narcolepsy	0.000809	0.00156	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—P2RY11—narcolepsy	0.000803	0.00155	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—PENK—narcolepsy	0.000792	0.00153	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR ligand binding—TAC1—narcolepsy	0.000788	0.00152	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR ligand binding—NPS—narcolepsy	0.000788	0.00152	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00077	0.00149	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—TRH—narcolepsy	0.000765	0.00148	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—TRH—narcolepsy	0.000758	0.00146	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000753	0.00146	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—HCRT—narcolepsy	0.000752	0.00145	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—TRH—narcolepsy	0.000741	0.00143	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR downstream signaling—HRH3—narcolepsy	0.000739	0.00143	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—HCRT—narcolepsy	0.000735	0.00142	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR ligand binding—TAC1—narcolepsy	0.000732	0.00142	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR ligand binding—NPS—narcolepsy	0.000732	0.00142	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000727	0.0014	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—HCRTR2—narcolepsy	0.000726	0.0014	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—HCRTR1—narcolepsy	0.000726	0.0014	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—PENK—narcolepsy	0.000721	0.00139	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—P2RY11—narcolepsy	0.000702	0.00136	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—TRH—narcolepsy	0.000688	0.00133	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—HCRT—narcolepsy	0.000683	0.00132	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—CPT1B—narcolepsy	0.000679	0.00131	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000675	0.00131	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—TRH—narcolepsy	0.000673	0.0013	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—HRH3—narcolepsy	0.000671	0.0013	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—PENK—narcolepsy	0.00067	0.00129	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—CHKB—narcolepsy	0.000667	0.00129	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—HRH3—narcolepsy	0.000664	0.00128	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—PENK—narcolepsy	0.000655	0.00127	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—HCRTR1—narcolepsy	0.000653	0.00126	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—HCRTR2—narcolepsy	0.000653	0.00126	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR ligand binding—HTR2A—narcolepsy	0.000652	0.00126	CbGpPWpGaD
Phenylpropanolamine—MAOA—SIDS Susceptibility Pathways—TNF—narcolepsy	0.00065	0.00126	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—HRH3—narcolepsy	0.00065	0.00126	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—HCRTR2—narcolepsy	0.000639	0.00123	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—HCRTR1—narcolepsy	0.000639	0.00123	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—narcolepsy	0.000637	0.00123	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—narcolepsy	0.000637	0.00123	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—P2RY11—narcolepsy	0.000631	0.00122	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000623	0.0012	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—P2RY11—narcolepsy	0.000617	0.00119	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—TRH—narcolepsy	0.000613	0.00119	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR downstream signaling—NPS—narcolepsy	0.000612	0.00118	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR downstream signaling—TAC1—narcolepsy	0.000612	0.00118	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—PENK—narcolepsy	0.000608	0.00118	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—HRH3—narcolepsy	0.000603	0.00117	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—HCRT—narcolepsy	0.000597	0.00115	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—HRH3—narcolepsy	0.00059	0.00114	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR ligand binding—HTR2A—narcolepsy	0.000586	0.00113	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000579	0.00112	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR ligand binding—HTR2A—narcolepsy	0.000573	0.00111	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—TRH—narcolepsy	0.00057	0.0011	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000562	0.00109	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—TRH—narcolepsy	0.000557	0.00108	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—NPS—narcolepsy	0.000556	0.00107	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—TAC1—narcolepsy	0.000556	0.00107	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—NPS—narcolepsy	0.000551	0.00106	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—TAC1—narcolepsy	0.000551	0.00106	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—NPS—narcolepsy	0.000539	0.00104	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—TAC1—narcolepsy	0.000539	0.00104	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—HRH3—narcolepsy	0.000538	0.00104	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—HCRT—narcolepsy	0.000536	0.00104	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—PENK—narcolepsy	0.000532	0.00103	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—HCRTR1—narcolepsy	0.000528	0.00102	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—HCRTR2—narcolepsy	0.000528	0.00102	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—HCRT—narcolepsy	0.000525	0.00101	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—TRH—narcolepsy	0.000517	0.001	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—P2RY11—narcolepsy	0.00051	0.000987	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—TAC1—narcolepsy	0.0005	0.000966	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—NPS—narcolepsy	0.0005	0.000966	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—HRH3—narcolepsy	0.000499	0.000966	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—HCRTR1—narcolepsy	0.000491	0.000949	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—HCRTR2—narcolepsy	0.000491	0.000949	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—TAC1—narcolepsy	0.000489	0.000945	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—NPS—narcolepsy	0.000489	0.000945	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—HRH3—narcolepsy	0.000488	0.000944	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—PENK—narcolepsy	0.000478	0.000924	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—P2RY11—narcolepsy	0.000474	0.000917	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR ligand binding—HTR2A—narcolepsy	0.000474	0.000917	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—PENK—narcolepsy	0.000468	0.000904	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—HRH3—narcolepsy	0.000454	0.000877	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—CPT1B—narcolepsy	0.000453	0.000876	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—TRH—narcolepsy	0.000452	0.000874	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—NPS—narcolepsy	0.000445	0.000861	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—TAC1—narcolepsy	0.000445	0.000861	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR ligand binding—HTR2A—narcolepsy	0.000441	0.000852	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—HCRT—narcolepsy	0.000434	0.000839	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—TAC1—narcolepsy	0.000414	0.0008	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—NPS—narcolepsy	0.000414	0.0008	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—TRH—narcolepsy	0.000406	0.000786	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—TAC1—narcolepsy	0.000404	0.000782	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—NPS—narcolepsy	0.000404	0.000782	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—HCRT—narcolepsy	0.000403	0.000779	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—TRH—narcolepsy	0.000398	0.000769	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—HRH3—narcolepsy	0.000396	0.000766	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—PENK—narcolepsy	0.000387	0.000748	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—TAC1—narcolepsy	0.000376	0.000727	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—NPS—narcolepsy	0.000376	0.000727	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR downstream signaling—HTR2A—narcolepsy	0.000368	0.000712	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—CHKB—narcolepsy	0.000368	0.000712	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—PENK—narcolepsy	0.000359	0.000695	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—HRH3—narcolepsy	0.000356	0.000689	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—HRH3—narcolepsy	0.000349	0.000674	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—HTR2A—narcolepsy	0.000335	0.000647	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—HTR2A—narcolepsy	0.000331	0.00064	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—TRH—narcolepsy	0.000329	0.000636	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—TAC1—narcolepsy	0.000328	0.000635	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—NPS—narcolepsy	0.000328	0.000635	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—HTR2A—narcolepsy	0.000324	0.000626	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—TRH—narcolepsy	0.000306	0.000591	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—HTR2A—narcolepsy	0.000301	0.000581	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—NPS—narcolepsy	0.000295	0.000571	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—TAC1—narcolepsy	0.000295	0.000571	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—HTR2A—narcolepsy	0.000294	0.000569	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—TAC1—narcolepsy	0.000289	0.000558	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—NPS—narcolepsy	0.000289	0.000558	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—HRH3—narcolepsy	0.000288	0.000557	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—HTR2A—narcolepsy	0.000268	0.000518	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—HRH3—narcolepsy	0.000268	0.000518	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—CPT1B—narcolepsy	0.00025	0.000484	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—HTR2A—narcolepsy	0.000249	0.000481	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—HTR2A—narcolepsy	0.000243	0.00047	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—NPS—narcolepsy	0.000239	0.000462	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—TAC1—narcolepsy	0.000239	0.000462	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—HTR2A—narcolepsy	0.000226	0.000437	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—TAC1—narcolepsy	0.000222	0.000429	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—NPS—narcolepsy	0.000222	0.000429	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—HTR2A—narcolepsy	0.000198	0.000382	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—HTR2A—narcolepsy	0.000178	0.000343	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—HTR2A—narcolepsy	0.000174	0.000336	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—HTR2A—narcolepsy	0.000144	0.000278	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—HTR2A—narcolepsy	0.000134	0.000258	CbGpPWpGaD
